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Abstract
Objectives: To determine the prevalence of nasopharyngeal pneumococcus colonization in children with sickle
cell disease undergoing penicillin prophylaxis, to identify risk factors for colonization and to serotype and determine
antibiotic resistance in pneumococci obtained from those children.
Methods: Between April 9, 2002 and February 28, 2003, 188 nasopharyngeal swabs were obtained from 98
children with sickle cell disease in follow-up at the Hospital Sªo Paulo  Universidade Federal de Sªo Paulo.
Pneumococci were isolated and identified by standard methods. The minimal inhibitory concentration for penicillin
was determined by the E-test method. Isolates were serotyped with the use of type-specific antisera for 46 different
serotypes (Neufeld-Quellung reaction).
Results: The age of children ranged from 4 months to 17 years (median and standard deviation 6.8–4.7
years). Thirteen of the 98 children had nasopharyngeal pneumococcus colonization (13.3% prevalence). There
was a significantly greater risk of colonization among children less than 2 years old (p = 0.02). Twenty-one
percent of isolates had intermediate penicillin resistance. There were no isolates highly resistant to penicillin.
All isolates were susceptible to erythromycin, ceftriaxone, or vancomycin. The most frequently identified
serotypes were 18C and 23F.
Conclusions: Penicillin prophylaxis reduced pneumococcal nasopharyngeal colonization and did not increase
the prevalence of penicillin-resistant pneumococci in children with sickle cell disease. Penicillin can be used not only
for prophylaxis, but also in the acute management of febrile states with these children.
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Introduction
Several different studies have confirmed the relation
between nasopharyngeal colonization and the risk of
developing an invasive infection by Streptococcus
pneumoniae .1,2 The prevalence of nasopharynx
colonization by this bacteria can be influenced by many
different factors, such as age, geographical area, study
population, attendance at day care and prophylaxis with
penicillin for children with sickle-cell disease.3,4
The rate of nasopharyngeal colonization in Brazil varies
from 30 to 50% in children,5,6 but we could not find any
Brazilian studies that assessed children with sickle-cell
anemia. In the United States (USA), the rate of
nasopharyngeal colonization among such patients varies
from 5 to 17%, and these results cannot be extrapolated for
a different population.3,7,8
In the general population, Streptococcus pneumoniae
resistance to penicillin is becoming ever more common and
is a cause of concern all over the world.9 This concern
increases with relation to children with sickle-cell anemia
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who are exposed to prolonged penicillin usage in order to
reduce the risk of pneumococcal infection,10 which could
result in the selection of strains resistant to this
antimicrobial.11,12
Reported pneumococcus resistance to penicillin in Brazil
has varied from 15 to 36% for strains isolated from invasive
disease sufferers, with similar rates being found among
colonizing strains and almost all of such strains having an
intermediate level of penicillin resistance.5,6,13,14
Studies undertaken with the objective of assessing
pneumococcus resistance to penicillin in children with sickle
cell disease on prophylaxis with this antimicrobial have
returned conflicting results. Anglin et al.3 found intermediate
resistance in 2.9% of strains isolated from nasopharynx,
and Norris et al.7 found 33% penicillin resistance with 36%
of these exhibiting elevated resistance. In neither study was
any increased resistance in association with prophylaxis
observed. In contrast, Steele et al.8 performed a study
which found evidence of penicillin resistance in 62% of
strains, while a control group that had not been given
penicillin presented 41% resistance, associating the
increased resistance with prophylaxis.
The objectives of the current study are as follows: to
evaluate the prevalence of nasopharyngeal colonization by
Streptococcus pneumoniae in children with sickle-cell anemia
using prophylactic penicillin, to identify risk factors for
colonization and to verify the antimicrobial resistance profile
and the serotypes of the strains isolated.
Methods
The sectional study was performed at the Pediatric
Hematology Division of the Pediatric Specialties Course run
by the Pediatrics Department of the Universidade Federal de
Sªo Paulo, Escola Paulista de Medicina (UNIFESP-EPM),
Hospital Sªo Paulo, in the period from April 2002 to February
2003. The research protocol was approved by the Committee
for Ethics in Research at the Universidade Federal de Sªo
Paulo/Hospital Sªo Paulo.
The study population consisted of 98 patients, aged from
4 months to 17 years, whose sickle-cell anemia diagnoses
had been confirmed by isoelectric focusing test or by
electrophoresis of hemoglobin in alkaline pH, and who had
been using antimicrobial prophylaxis with penicillin
benzathine or penicillin V, for more than a month. All of the
patients were residents of Sªo Paulo state and the majority
lived in Greater Sªo Paulo.
Patients were excluded from the study if they did not
receive prophylaxis, were allergic to penicillin (and so were
on erythromycin) or if they had been given the 7-valent
antipneumococcal conjugated vaccine, since the conjugated
vaccine reduces nasopharyngeal colonization by the
serotypes it contains.15,16
At each consultation during the study period (generally
every 4 months), held at the Pediatric Hematology Clinic,
parents or guardians were interviewed by questionnaires
by the researcher. Epidemiological data were obtained at
these interviews relating to: (1) the child (age, sex, race,
genotype [HbSS, HbSC or HbS-beta thalassemia],
attendance at day care or school); (2) prophylaxis (period
of use, type of medication and compliance); (3) vaccination
(with respect of  the 23-valent polysacchar ide
pneumococcal vaccine); (4) current infections or infections
during the 3 months prior to collecting material from the
nasopharynx; (5) current or during the previous 3 months
use of antibiotics, with the exception of prophylaxis; (6)
hospitalizations during the previous 3 months; (7) living
conditions.
Nasopharynx samples were collected during the
consultations at the clinic, at minimum intervals of 30 days,
by means of sterile swabs with flexible stalks, which were
introduced carefully via the childrens nostrils to a depth
corresponding to two thirds of the distance between their
nose and earlobe.17 Next the swab was immersed in the
appropriate Amies transport medium and sent, 1 to 2 hours
after collection, at ambient temperature to the bacteriology
section at the Instituto Paulista de Doenças Infecciosas e
ParasitÆrias, affiliated to UNIFESP.
The material was inoculated on plates containing 5%
sheep blood agar. The plates were incubated at 35–1 °C,
with 5 to 10% CO2, in an atmosphere produced by a candle
jar, for 24 hours. The presence of a gray-green zone around
colonies (alpha-hemolysis) was presumed to indicate
Streptococcus pneumoniae. The agent was confirmed by
rapid latex agglutination test and by assessment of the
inhibition zone around a disk of optochin and, if necessary
a bile solubility test was also performed.
Penicillin susceptibility was assessed by means of the
oxacillin disc diffusion method (1 µg), with an inhibition
zone > 20 mm considered indicative of susceptibility to
penicillin, and a halo < 19 mm, as resistance to penicillin.
Minimum inhibitory concentration (MIC) for penicillin was
determined by the E-test method for all strains of
pneumococcus resistant to oxacillin (halo < 19 mm). The
MIC for penicillin values were interpreted as susceptible if
< 0.06 µg/ml, intermediate from 0.1 to 1 µg/ml and as
resistant if > 2.0 µg/ml.18 Bacterial resistance to
erythromycin, cotrimoxazole, levofloxacin, ceftriaxone and
vancomycin were also determined by the E-test.
Serotyping of the isolated pneumococcus strains was
performed at the Instituto Adolfo Lutz by means of the
Neufeld-Quellung reaction using antisera produced at the
Statem Serum Institute, in Copenhagen, Denmark.
A descriptive analysis was performed of the profiles of
the patients and pneumococcus strains. In order to test
the significance of differences between the subsets of
colonized and uncolonized children Pearsons chi-square
test was applied. The descriptive cutoff (p) < 0.05 or 5%
was considered statistically significant for rejecting the
equality hypothesis.
Results
Ninety-eight patients with sickle-cell anemia were
enrolled, with ages varying from 4 months to 17 years,
giving mean and standard deviation of 6.8–4.7 years, with
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23 children (23.5%) aged < 24 months, 22 (22.5%) from 25
to 71 months and 53 (54%) > 72 months of age. Genotypes
were as follows: 69 patients (70.4%) had sickle-cell anemia
(HbSS), 18 (18.4%) were HbSC carriers, and 11 (11.2%),
had HbS-beta thalassemia.
With respect of the type of prophylaxis, 82 patients
(83.7%) were using penicillin benzathine and 16 (16.3%)
penicillin V. The duration of prophylaxis varied from 1 month
to 14 years, with a mean of 4.4–3.4 years. With respect of
compliance with prophylaxis, it was observed that 72
patients (73.5%) claimed that they took their medication
regularly. The 23-valent antipneumococcal polysaccharide
vaccine had been given to 68 children (69.4%).
Pneumococcus was isolated from the nasopharynx of 13
of the 98 children, equating to a colonization rate of 13.3%
(95% CI: 7 to 22%). Just one nasopharynx material sample
was collected from 28 of the children, two samples from 50
children and three samples from 20 children. A total of 188
samples from the nasopharynx were obtained, of which 14
were positive for pneumococcus, isolating the agent from
7.4% (95% CI: 4 to 12%) of the swabs. One of the 13
colonized children, therefore, provided two samples that
were positive for Streptococcus pneumoniae.
Just one child (1/13, 7.7%) presented sinusitis after the
nasopharynx culture presented pneumococcus, five patients
(38.5%) had no infection after the bacteria was isolated,
with the next sample being negative, and seven (53.8%) did
not return to the clinic after the positive sample.
Age was the only risk factor for colonization, with
patients aged < 24 months being most colonized
(7/13 = 30.4%) compared to the other age groups. No
other risk factors for nasopharyngeal colonization were
identified (Table 1).
Five of the 14 strains isolated (35.7%) exhibited
resistance to screening with oxacillin discs. The results of
the MIC evaluation showed that three of the five strains
tested exhibited intermediate penicillin resistance, all with
an MIC of 0.25 µg/ml, which is equivalent to a resistance
rate of 21.4% (3/14). No strains with elevated resistance to
penicillin were observed. Of the 98 children assessed, three
(3.1%) had been colonized by resistant strains. No resistance
was observed to erythromycin, ceftriaxone or vancomycin.
Nine strains (64.3%) were resistant to cotrimoxazole and
six (42.9%), to levofloxacin.
Thirteen of the 14 strains isolated from the 13 colonized
patients were serotyped. The serotypes found and their
respective susceptibilities to penicillin are listed in Table 2.
Discussion
Since the first studies of Streptococcus pneumoniae
colonization were performed, authors have been concluding
that the rate of isolation of the bacteria and, as a result, the
identification of carrier status depend, in addition to other
factors, on the methodology utilized. In 1996, Norris et al.7
assessed colonization by pneumococcus in children with
sickle-cell anemia, obtaining material with swabs of the
nasopharynx or oropharynx, and found that the number of
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samples positive for Streptococcus pneumoniae was
significantly greater when the material was obtained from
the nasopharynx. Based on this data our study employed
samples taken from the nasopharynx.
It was in 1984 that Anglin et al. 3 published the first study
to assess the effect of prophylactic penicillin on
nasopharyngeal colonization and found a prevalence of
11.1% among sickle-cell sufferers and 37.1% in a control
group with no prophylaxis. Other authors have found
colonization rates of children with sickle-cell anemia using
penicillin that vary from 8 to 15.5%.7,19,20 In our study we
found results comparable to these, with a colonization rate
of 13.3%. Nevertheless, we should point out that the
majority of our patients used penicillin benzathine, in
contrast with all these studies in which the patients were on
oral penicillin V.
If we compare the prevalence of colonization found in
this study with that of others also performed in Brazil, but
involving children without sickle-cell anemia, we find that
our patients have a lower rate of colonization. In Sªo Paulo,
the rate of pneumococcal colonization of children under 5
years of age was 34.8%5 and, in Fortaleza it was 55%.6 It
we consider just the children under 72 months old in our
study we observe a prevalence of 20%, which is lower than
that found in these studies involving normal children,
suggesting that the prophylaxis with penicillin benzathine
reduced colonization by Streptococcus pneumoniae.
Several different studies have shown that the age of the
child interferes with the prevalence Streptococcus
pneumoniae colonization, with more colonization of children
less than 2 years of age.4,21,22 Studying children with
sickle-cell anemia, Steele et al.8 observed 33% colonization
of children less than 2 years old, 10% for those between 2
and 5 years and 6% above 5 years, which results are very
similar to those found by Norris et al.7 and in the present
study. This confirms that patients less than 2 years old have
a greater risk of colonization.
Compliance with antimicrobial prophylaxis did not have
any influence on the prevalence of colonization, which is
probable the result of the small number of colonized patients
in the study, to the method used to assess compliance and
to interference by other variables such as patient age.4,22
Immunization with the 23-valent polysaccharide
antipneumococcal vaccine appears not to reduce the
prevalence of nasopharyngeal colonization by Streptococcus
pneumoniae,23 in common with what we observed in our
study; some immunized children had been colonized by
serotypes in the vaccine.
The presence of other children less than 5 years old at
home and attendance at day care centers are risk factors for
colonization.5,6,24 We did not find the same result, probably
due to the low number of patients with siblings less than 5
years old and the low percentage of patients under 6 years
old who attend day care or school in our study.
We did not verify any increased pneumococcal penicillin
resistance when we compared our data with a number of
different studies performed in Brazil, involving both invasive
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Table 1 - Risk factors among children with sickle cell disease colonized or not with Streptococcus pneumoniae
Risk factor n colonized n non-colonized p
total = 13 total = 85
n (%) n (%)
Age
< 24 months 7 (30.4%) 16 (69.6%) 0.02*
25 to 71 months 2 (9.1%) 20 (90.9%)
> 72 months 4 (7.5%) 49 (92.5%)
Genotype
SS e Sß 11 (13.8%) 69 (86.2%) 0.77
SC 2 (11.1%) 16 (88.9%)
Prophylaxis
Penicillin V 11 (13.4%) 71 (86.6%) 0.92
Penicillin benzathine 2 (12.5%) 14 (87.5%)
Compliance
Regular 12 (16.7%) 60 (83.3%) 0.19
Irregular 1 (3.8%) 25 (96.2%)
Pneumo-23 Vaccine
Yes 6 (8.8%) 62 (91.2%) 0.10
No 7 (23.3%) 23 (76.7%)
Children under 5 years at home
Yes 3 (9.1%) 30 (90.9%) 0.58
No 10 (15.4%) 55 (84.6%)
Children under 6 years (n = 52)
in day care centers or schools
Yes 2 (22.2%) 7 (19.4%) 0.85
No 7 (77.8%) 36 (80.6%)
Patient Serotype Age 23-valent Penicillin
n vaccine susceptibility
1 18C 22 months no S
2 23F 5.4 years yes S
2 * 5.7 years yes S
3 6B 8.8 years yes S
4 NT 7 years yes I
5 19F 10 months no S
6 10A 7.8 years yes S
7 NT 9 years yes S
8 23B 5.3 years yes I
9 19A 20 months no S
10 6A 6 months no S
11 23F 10 months no I
12 33 6 months no S
13 18C 7 months no S
Table 2 - Serotypes found, age and vaccines according to the colonized patient and susceptibility to penicillin of
the 14 isolated strains
* No serotyping performed; NT = non-serotyped by the method; S = sensitive; I = intermediate resistance.
* Chi-square test with two degrees of freedom.
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and colonizing strains;5,6,13,14 this would appear to indicate
that penicillin is still safe both for prophylaxis and for initial
treatment of febrile episodes in anemic children.
Around 50 to 80% of penicillin-resistant strains are also
resistant to cotrimoxazole.5,14 The high frequency of
resistance to cotrimoxazole that has been observed in a
number of different studies (63 to 81%), including ours,
rules out the use of this antibiotic for the treatment of
pathologies of which pneumococcus is the principal etiologic
agent. In our sample we found 42.9% of strains were
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resistant to levofloxacin, which conflicts with published
literature in which 99% of pneumococcus strains isolated
were sensitive to this antimicrobial.25 Despite our sample
being small, this result indicates greater than expected
resistance. The frequency of pneumococcal resistance to
ceftriaxone remains low, with rates varying from 0 to 8%
depending on location.5,6,13,19 In the entirety of the literature
evaluated to date, there are no pneumococcus strains
resistant to vancomycin.
The number of strains isolated from our population
was small, and as such the true prevalence of the
serotypes cannot be determined. The majority of the
strains found (69.2%) in our population were members of
the principle serotypes responsible for invasive disease in
Brazil.26 With respect of serogroups, we observed that
the most frequent were 23 (23.1%), 6 (15.4%), 19
(15.4%) and 18 (15.4%), similar values to those found in
developed countries, since serogroups 6, 14, 19 and 23
predominate in the infections of children all over the
world, and 18 in developed countries.27 Infections caused
by serotypes 1 and 5 are common in our country,27 and
probably were not isolated because they are not very
common in nasopharyngeal colonization.28 These data
confirm the usefulness of studying nasopharyngeal
colonization for monitoring the profile of invasive strains.
We conclude that both prophylaxis with oral penicillin
V and with penicillin benzathine contribute to reducing
nasopharyngeal colonization of sickle-cell patients,
although those younger than 24 months of age remain at
greater risk of colonization, despite prophylaxis, and also
that prolonged penicillin use does not result in an increase
in pneumococcus resistance to this antimicrobial, and
appears to retain its efficacy.
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